Evidence map›Paper›PMID 40395845›Full record

ArticleBio-protocol2025

Sensitive and Adaptable Turn-On Maturation (ATOM) Fluorescent Biosensors for Detecting Subcellular Localization of Protein Targets in Cells.

Harsimranjit Sekhon, Jeung-Hoi Ha, Stewart N Loh

Abstract read
In one paragraph

Article in Bio-protocol, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Harsimranjit SekhonDepartment of Biochemistry and Molecular Biology, SUNY Upstate Medical University, Syracuse, NY, USA.
Jeung-Hoi HaDepartment of Biochemistry and Molecular Biology, SUNY Upstate Medical University, Syracuse, NY, USA.
Stewart N LohDepartment of Biochemistry and Molecular Biology, SUNY Upstate Medical University, Syracuse, NY, USA.

Funding

Combining protein and DNA engineering to create bioswitchesR01GM148448 · NIGMS · UPSTATE MEDICAL UNIVERSITY · PI LOH, STEWART N · 2022 to 2025
$1.6M
Design of switchable proteins and enzymes.R01GM115762 · NIGMS · UPSTATE MEDICAL UNIVERSITY · PI LOH, STEWART N · 2015 to 2018
$1.3M
Molecular Devices for the Detection and Treatment of HCMV InfectionF30GM146428 · NIGMS · UPSTATE MEDICAL UNIVERSITY · PI Harsimranjit S Sekhon · 2022 to 2026
$268k
NIGMS NIH HHS F30 GM146428NIGMS NIH HHS R01 GM115762NIGMS NIH HHS R01 GM148448
6 · The paper itself

Abstract

Fluorescent protein biosensors (FPBs) that turn on-go from dark to bright upon binding their ligands-enable the detection of targets in living cells with high sensitivity and spatial localization. Several approaches exist for creating turn-on FPBs, most notably the method that gave rise to the GCaMP family of genetically encoded calcium indicators. However, it remains challenging to modify these sensors to recognize new ligands. We recently developed adaptable turn-on maturation (ATOM) biosensors, in which target recognition by a small binding domain triggers chromophore maturation in the fluorescent protein to which it is attached. ATOM sensors are advantageous because they are generalizable (by virtue of the monobody and nanobody binding domains) and modular (binding domains and fluorescent proteins of various colors can be mixed and matched for multiplexed imaging), capable of detecting endogenously expressed proteins, and able to function in subcellular compartments including the cytoplasm, nucleus, endoplasmic reticulum, and mitochondria. The protocols herein detail how to design, clone, and screen new ATOM sensors for detecting targets of choice. The starting materials are the genes encoding for a monobody or nanobody and for a cyan, yellow, or red fluorescent protein. We also present general guidelines for creating ATOM sensors using binding domains other than nanobodies and monobodies. Key features • Creation of six-member (monobody-based) and nine-member (nanobody-based) plasmid libraries encoding ATOM biosensors. • Targeting ATOM biosensors to subcellular compartments using peptide tags. • Screening for biosensor activity in human cells and quantifying turn-on using a fluorescence microscope and freeware software packages. • The most time-consuming step is ATOM gene construction, which can be bypassed by commercial gene synthesis.

Indexed as

ATOMBiosensorCircular permutationEndogenous protein detectionFluorescenceGenetically encodedMonobodyNanobodySubcellular localization

Identifiers

PMID40395845
PMCPMC12086338

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.